Plant Construction & Process Technology

Consolidation is here to Stay

28.09.2017 - Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass,...

Plant Construction & Process Technology

Changes in Portfolios and Pipelines are Likely

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...

Plant Construction & Process Technology

Setting High Standards

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...

Plant Construction & Process Technology

A Partner to Relieve the Strain

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

28.09.2017 - Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

27.09.2017 - There is a regulatory expectation that pharmaceutical companies will verify that the excipients produced by their suppliers are to an appropriate level of GMP . This has been...

Plant Construction & Process Technology

Supply Chain Integrity and Patient Safety

27.09.2017 - Investigation into future trends in the medical and pharmaceutical sector shows that digitalization is changing supply chains in the healthcare industry. Such diverse issues like...

Plant Construction & Process Technology

The Expanding Role of Contract Manufacturing

27.09.2017 - In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...